⌘K

Login Start Free

Home/Filings/4/0001144204-19-028259

4//SEC Filing

Patrick Todd 4

Accession 0001144204-19-028259

CIK 0000921114other

View on SEC.gov Company Profile

Filed

May 23, 8:00 PM ET

Accepted

May 24, 9:30 PM ET

Size

5.5 KB

Accession

0001144204-19-028259

Insider Transaction Report

Form 4

Period: 2019-05-22

Armata Pharmaceuticals, Inc.ARMP

DirectorChief Executive Officer

Transactions

Award
Stock Option (Right to Buy)
2019-05-22+298,724→ 298,724 total
Exercise: $3.15Exp: 2029-05-22→ Common Stock (298,724 underlying)

Footnotes (1)

[F1]The stock option vests as to twenty-five percent (25%) of the underlying shares of common stock on each annual anniversary of the date of grant.

Documents

1 file

4
tv522365_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Armata Pharmaceuticals, Inc.

CIK 0000921114

Entity typeother

Related Parties

1

filerCIK 0001762285

Filing Metadata

Form type: 4
Filed: May 23, 8:00 PM ET
Accepted: May 24, 9:30 PM ET
Size: 5.5 KB

View on SEC.gov